Christine has had an infatuation with video games since she was a child, starting with games such as Diablo 2 and Morrowind. Her current obsessions include Final Fantasy 14, Genshin Impact, and Dragon ...

Michael Ingram is a Senior Contributor from the United States of America. Michael has been writing for GameRant since 2021 with a previous history of personal analytical writing. Michael is a lifelong ...

PS Plus Extra, Premium users are warned not to download an October 2025 game without checking their PS5, PS4 libraries first. Yakuza: Like a Dragon was part of PS Plus Essential monthly lineup in ...

We’ve been raising concerns about this issue since Sony revamped PS Plus, and it still hasn’t been fixed. My last article on this topic was published a year ago, and I continue to see complaints from ...

However, recently, players have experienced something called the Global Game Quota Exceeded error, which essentially indicates that the servers on the Portal feature are currently full. EA’s Portal ...

Even after the bye week, the hits keep coming for the West Virginia Mountaineers. On Thursday night, the team officially ruled out starting defensive lineman Hammond Russell IV, making him the 10th ...

Oct 23 (Reuters) - AI data centre startup Crusoe is raising $1.38 billion at a valuation of about $10 billion from an anticipated Series E funding round, the Denver-based company said on Thursday The ...

Forbes contributors publish independent expert analyses and insights. Aisha Nyandoro is a leading voice on equitable economic policies.

The have an early injury concern in the first half of the Week 6 game against the , as linebacker Fred Warner is hurt. Warner went down with an injury in the first quarter of the contest and it is ...

There have been no days off and no bad games for Indianapolis Colts star running back Jonathan Taylor so far this season. Sunday was Taylor's latest big game to further show he has a legitimate case ...

Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.

Europe’s leading cancer conference may be swimming in antibody-drug conjugate data, but AstraZeneca remains convinced that its in-house pipeline sets the pharma apart. The U.K.-based drugmaker earned ...